Skip to main content

Advertisement

Log in

Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose . A series of polymorphisms in germ-line DNA have been investigated in an effort to delineate polygenic models of cancer susceptibility and prognosis. As low-penetrance susceptibility genes may combine additively or multiplicatively and contribute to cancer incidence and to the response to chemotherapy, we studied GSTT1, GSTM1, GSTO2, GSTP1 and codon 72 of p53 genotype profiles in ovarian cancer patients. Methods . We compared 69 ovarian cancer patients with 222 control healthy women paired for ethnic and life-style characteristics. Outcome was evaluated in 29 stage III and IV patients submitted to a platinum-based chemotherapy followed-up for 6–29 months (17 ± 9 months). Results . GSTT1, GSTM1, GSTO2 and GSTP1 genes presented a similar genotype distribution, but codon 72 of p53 gene wild-type variant was less frequent in ovarian cancer patients than in controls (χ2; = 0.0004). Conclusions. We were unable to demonstrate any association between the GST genotypes studied and the risk of ovarian cancer but the inheritance of a heterozygous Arg/Pro genotype of p53 increased the risk of ovarian cancer more than 2.5 times (OR = 2.571; 95% CI = 1.453–4.550). There was no association of the studied genes to any clinical or pathological feature of the patients or to their response to chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Agorastos T, Masouridou S, Lambropoulos AF, Chrisafi S, Miliaras D, Pantazis K, Constantinides TC, Kotsis A, Bontis I (2004) P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur J Cancer Prev 13:277–280

    Article  PubMed  CAS  Google Scholar 

  • Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, Niitsu Y (1996) Transfection of glutathione S-transferase (GST) –pi antisense complementary DNA increases the sensitivity of a colon cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res 56:3577–3582

    PubMed  CAS  Google Scholar 

  • Baxter SW, Thomas EJ, Campbell IG (2001) GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis 22:63–66

    Article  PubMed  CAS  Google Scholar 

  • Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, Beckman L (1994) Is p53 polymorphism maintained by natural selection? Hum Hered 44:266–270

    Article  PubMed  CAS  Google Scholar 

  • Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H (2006) Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 100:330–337

    Google Scholar 

  • Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T (2003) P53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 3:387–402

    Article  PubMed  CAS  Google Scholar 

  • Birgander R, Sjalander A, Rannug A, Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Beckman G, Beckman L (1995) P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16:2233–2236

    Article  PubMed  Google Scholar 

  • Board PG (1981) Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet 33:36–43

    PubMed  CAS  Google Scholar 

  • Buller RE, Sood A, Fullenkamp C, Sorosky J, Powills K, Anderson B (1997) The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther 4:239–245

    PubMed  CAS  Google Scholar 

  • Buyru N, Tigli H, Dalay N (2003) P53 codon 72 polymorphism in breast cancer. Oncol Rep 10:711–714

    PubMed  CAS  Google Scholar 

  • Clapper ML, Tigle H (2000) Genetic polymorphism and cancer risk. Curr Oncol Rep 2:251–256

    Article  PubMed  CAS  Google Scholar 

  • Coughlin SS, Hall I (2002) Glutathione S-transferase olymorphisms and risk of ovarian cancer: a Huge review. Genet Med 4:250–257

    Article  PubMed  CAS  Google Scholar 

  • Dong M, Nio Y, Yamasawa K, Toga T, Yue L, Harada T (2003) p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. J Surg Oncol 82:111–120

    Article  PubMed  CAS  Google Scholar 

  • Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS (2002) TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res 22:3379–3381

    PubMed  CAS  Google Scholar 

  • Dulhunty A, Gage P, Curtis S, Chelvanayagam G, Board P (2001) The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J Biol Chem 276:3319–3323

    Article  PubMed  CAS  Google Scholar 

  • Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365

    Article  PubMed  CAS  Google Scholar 

  • Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC (2000) The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9:1037–1042

    PubMed  CAS  Google Scholar 

  • Gaffey MJ, Iezzoni JC, Meredith SD, Boyd JC, Stoler MH, Weiss LM, Zukerberg LR, Levine PA, Arnold A, Williams ME (1995) Cyclin D1 (PRAD1, CCND1) and glutathione S-transferase pi gene expression in head and neck squamous cell carcinoma. Hum Pathol 26:1221–1226

    Article  PubMed  CAS  Google Scholar 

  • Ganmaa D, Sato A (2005) The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Med Hypotheses 65:1028–1037

    Article  PubMed  CAS  Google Scholar 

  • Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, Lazarous DF, Pierce L, d’Angelo T, Moscow JA, et al. (1993) A pilot study of pi-class glutathione S-transferase in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11:49–58

    PubMed  CAS  Google Scholar 

  • Granja F, Morari EC, Assumpcao LV, Ward LS (2005) GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy. Euro J Cancer Prev 14:277–280

    Article  CAS  Google Scholar 

  • Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS (2004) Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 210:151–157

    Article  PubMed  CAS  Google Scholar 

  • Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V (1986) Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6:4650–4656

    PubMed  CAS  Google Scholar 

  • Hogdall EVS, Hogdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, Vuust J, Norgard-Pedersen B, Kjaer SK (2002) Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significancer in ovarian cancer patients. Anticancer Res 22:1859–1864

    PubMed  CAS  Google Scholar 

  • Howells RE, Redman CW, Dhar KK, Sarhanis P, Musgrove C, Jones PW, Alldersea J, Fryer AA, Hoban PR, Strange RC (1998). Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res 4:2439–2445

    PubMed  CAS  Google Scholar 

  • Howells RE, Holland T, Dhar KK, Redman CW, Hand P, Hoban PR, Jones PW, Fryer AA, Strange RC (2001) Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival. Int J Gynecol Cancer 11:107–112

    Article  PubMed  CAS  Google Scholar 

  • Hu X, Ji X, Srivastava SK, Xia H, Awasthi S, Nanduri B, Awasthi YC, Zimniak P, Singh SV (1997) Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 345:32–38

    Article  PubMed  CAS  Google Scholar 

  • Iwai K, Mizuno S, Miyasaka Y, MoriT (2005) Correlation between suspended particles in the environmental air and causes of disease among inhabitants: cross-sectional studies using the vital statistics and air pollution data in Japan. Environ Res 99:106–117

    Article  PubMed  CAS  Google Scholar 

  • Johansson AS, Stenberg G, Widersten M, Mannervik B (1998) Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 278:687–698

    Article  PubMed  CAS  Google Scholar 

  • Klaes R, Ridder R, Schaefer U, Benner A, von Knebel Doeberitz M (1999) No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer. J Mol Med 77:299–302

    Article  PubMed  CAS  Google Scholar 

  • Knudsen LE, Loft SH, Autrup H (2001) Risk assessment: the importance of genetic polymorphisms in man. Mutat Res 482:83–88

    PubMed  CAS  Google Scholar 

  • Koushik A, Robert W, Platt RW, Franco EL (2004) p53 Codon 72 Polymorphism and Cervical Neoplasia A Meta-Analysis Review. Cancer Epidemiol Biomarkers Prev 13:11–22

    Article  PubMed  CAS  Google Scholar 

  • Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, Sellers TA (1999) Prospective study of diet and ovarian cancer. Am J Epidemiol 149:21–31

    PubMed  CAS  Google Scholar 

  • Lallas TA, McClain SK, Shahin MS, Buller RE (2000) The glutathione S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prev 9:587–590

    PubMed  CAS  Google Scholar 

  • Langseth H, Kjaerheim K (2004) Ovarian cancer and occupational exposure among pulp and paper employees in Norway. Scand J Work Environ Health 30:356–361

    PubMed  Google Scholar 

  • Mannervik B (1985) The isozymes of glutathione S-transferase. Adv Enzymol 57:357–417

    PubMed  CAS  Google Scholar 

  • Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG Jr (2000) A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25:47–54

    Article  PubMed  CAS  Google Scholar 

  • Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV (1987) Primary structure polymorphisms at amino acid residue 72 of human p53. Mol Cell Biol 7:961–963

    PubMed  CAS  Google Scholar 

  • Medeiros R, Pereira D, Afonso N, Palmeira C, Faleiro C, Afonso-Lopes C, Freitas-Silva M, Vasconcelos A, Costa S, Osorio T, Lopes C (2003) Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome. Int J Clin Oncol 8:156–161

    Article  PubMed  CAS  Google Scholar 

  • Morari EC, Leite JLP, Granja F, Assumpcao LVM, Ward LS (2002) The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 11:1485–1488

    PubMed  CAS  Google Scholar 

  • Ngan HY, Liu VW, Liu SS (1999) Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 80:1828–1829

    Article  PubMed  CAS  Google Scholar 

  • Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S (2004) Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Lett 210:197–203

    Article  PubMed  CAS  Google Scholar 

  • Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10:431–442

    Article  PubMed  CAS  Google Scholar 

  • Pegoraro RJ, Moodley M, Rom L, Chetty R, MoodleyJ (2003) P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans. Int J Gynecol Cancer 13:444–449

    Article  PubMed  CAS  Google Scholar 

  • Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemistry 300:271–276

    CAS  Google Scholar 

  • Qie M, ZhangY, Wu J (2002) Study on the relationship between cervical cancer and p53 codon 72 polymorphism. Hua Xi Yi Ke Da Xue Xue Bao 33:274–275

    PubMed  CAS  Google Scholar 

  • Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ (1998) p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352:871–872

    Article  PubMed  CAS  Google Scholar 

  • Russo D, Marie JP, Zhou DC, Faussat AM, Delmer A, Maisonneuve L, Ngoc LH, Baccarani M, Zittoun R (1994) Coexpression of anionic glutathione S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias. Leukemia 8:881–884

    PubMed  CAS  Google Scholar 

  • Siddique M, Sabapathy K (2006) Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 2006 Feb 6; [Epub ahead of print]

  • Seidegard J, Vorachek WR, Pero RW, Pearson WR (1988) Hereditary differences in the expression of human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85:7293–7297

    Article  PubMed  CAS  Google Scholar 

  • Shen H, ZhengY, Sturgis EM, Spitz MR, Wei Q (2002) P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 183:123–130

    Article  PubMed  CAS  Google Scholar 

  • Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G (2001) Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 22:67–72

    Article  PubMed  CAS  Google Scholar 

  • Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of p53 polymorphism in the development of human papilloma-virus-associated cancer. Nature 21:229–234

    Google Scholar 

  • Tanaka-Kagawa T, Jinno H, Hasegawa T, Makino Y, Seko Y, Hanioka N, Ando M (2003) Functional characterization of two variant human GSTO1-1s (Ala140Asp and Thr217Asn). Biochem. Biophys Res Commun 301:516–520

    Article  PubMed  CAS  Google Scholar 

  • Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, Tsai CH (2002) Prognostic Significance of the proline form of the p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 112:116–119

    Article  PubMed  CAS  Google Scholar 

  • Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, Nishiyama K, Yasuda M, Ueki M (2006) Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol 100:173–178

    Google Scholar 

  • Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Trope CG, Borresen-Dale AL, Kristensen GB (2004) TP53 mutations in early stage ovarian carcinoma, relation to long-term survival. Br J Cancer 90:678–685

    Article  PubMed  CAS  Google Scholar 

  • Wang YC, Lee HS, Chen SK, Chang YY, Chen CY (1999a) Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35:226–230

    Article  CAS  Google Scholar 

  • Wang YC, Chen CY, Chen SK, Chang YY, Lin P (1999b) p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5:129–134

    CAS  Google Scholar 

  • Weston A, Godbold JH (1997) Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Environ Health Persp 105:919–926

    Article  CAS  Google Scholar 

  • Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF, Harris CC (1994) Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15:583–587

    Article  PubMed  CAS  Google Scholar 

  • Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG (2003) Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131–144

    Article  PubMed  CAS  Google Scholar 

  • Wu WJ, Kakehi Y, Habuchi T, Kinoshita H, Ogawa O, Terachi T, Huang CH, Chiang CP, Yoshida O (1995) Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. Jpn J Cancer Res 86:730–736

    PubMed  CAS  Google Scholar 

  • Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ (1999) A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29:697–702

    Article  PubMed  CAS  Google Scholar 

  • Yung WC NG MH, Sham JS, Choy DT (1997) p53 codon 72 polymorphism in nasopharyngeal carcinoma. Cancer Genet. Cytogenet 93:181–182

    Article  PubMed  CAS  Google Scholar 

  • Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M (1999) Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354:218–219

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Sterian Ward.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morari, E.C., Lima, A.B.C., Bufalo, N.E. et al. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol 132, 521–528 (2006). https://doi.org/10.1007/s00432-006-0099-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-006-0099-3

Keywords

Navigation